|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 9/08 | (2006.01) |
| A61K 38/08 | (2006.01) | ||
| A61P 5/00 | (2006.01) | ||
| A61P 3/14 | (2006.01) |
| (11) | Number of the document | 3013318 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14742093.9 |
| Date of filing the European patent application | 2014-06-27 | |
| (97) | Date of publication of the European application | 2016-05-04 |
| (45) | Date of publication and mention of the grant of the patent | 2017-04-19 |
| (46) | Date of publication of the claims translation | 2017-09-11 |
| (86) | Number | PCT/US2014/044622 |
| Date | 2014-06-27 |
| (87) | Number | WO 2014/210489 |
| Date | 2014-12-31 |
| (30) | Number | Date | Country code |
| 201361840618 P | 2013-06-28 | US |
| (72) |
MACLEAN, Derek, US
YIN, Qun, US
|
| (73) |
Amgen Inc.,
One Amgen Center Drive, Thousand Oaks, California 91320,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Stabili AMG 416 (velcalcetide) kompozicija |
| STABLE LIQUID FORMULATION OF AMG 416 (VELCALCETIDE) |
| Payment date | Validity (years) | Amount | |
| 2025-05-20 | 12 | 289.00 EUR |
| 2026-06-27 |